The CoreMed Corporation is dedicated to helping pharmaceutical and biopharmaceutical companies efficiently and expeditiously navigate the regulatory approval process from the early development stage to product registration in Japan. CoreMed provides a full range of regulatory and development strategy consulting services, including regulatory strategic planning, pre-clinical and pharmacology/toxicology assessment, clinical study design, clinical compliance audits, review/preparation of regulatory applications, representation and/or liasion with regulatory agencies and performing R&D due diligence and expert witness services. Over the years, CoreMed has grown into one of the largest consultancy companies, offering high quality regulatory and drug registration consultancy services throughout the world.

CoreMed puts the highest priority on maintaining  a close relationship with clients and it's abiding aim is to approach new projects from the clients point of view. Quality and client orientation are the principal concerns. Many European and American pharmaceutical companies have been successful in Japan with the professional support of CoreMed.

For further information, see www.coremed.co.jp